Skip to main content
Premium Trial:

Request an Annual Quote

Perlegen and GlaxoSmithKline Enter New Pharmacogenomics Collaboration

NEW YORK, Oct. 12 (GenomeWeb News) - Perlegen Sciences said today that it will commence a high-density whole-genome scanning project with GlaxoSmithKline for the purposes of determining genetic variants associated with a specific GSK trait of interest, the second such collaboration between the companies.

 

GSK and Perlegen inked a similar agreement in September 2002. That project differed from the new collaboration in the specific trait of interest, Paul Cusenza, vice president of alliance management at Perlegen said.

 

Financial terms of the deal were not disclosed.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.